Google News

AstraZeneca investors punish firm over reports of $400-billion Bristol Myers pharma deal - The Globe and Mail

Aug 3, 2026, 7:00 PM

Translate article text

Choose a language and wait for the translated text.

AstraZeneca investors punish firm over reports of $400-billion Bristol Myers pharma deal  The Globe and Mail